Vivaldi Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,722
| Closed | -$218K | – | 337 |
|
|
2021
Q2 | $218K | Sell |
1,722
-213
| -11% | -$27K | 0.04% | 216 |
|
|
2021
Q1 | $206K | Buy |
1,935
+27
| +1% | +$2.87K | 0.04% | 226 |
|
|
2020
Q4 | $292K | Buy |
+1,908
| New | +$292K | 0.06% | 189 |
|
|
2018
Q4 | – | Sell |
-5,006
| Closed | -$222K | – | 201 |
|
|
2018
Q3 | $222K | Buy |
5,006
+6
| +0.1% | +$266 | 0.12% | 121 |
|
|
2018
Q2 | $294K | Buy |
+5,000
| New | +$294K | 0.24% | 98 |
|